These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32469918)

  • 1. Molecular interactions between monoclonal oligomer-specific antibody 5E3 and its amyloid beta cognates.
    Khorvash M; Blinov N; Ladner-Keay C; Lu J; Silverman JM; Gibbs E; Wang YT; Kovalenko A; Wishart D; Cashman NR
    PLoS One; 2020; 15(5):e0232266. PubMed ID: 32469918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From monomer to fibril: Abeta-amyloid binding to Aducanumab antibody studied by molecular dynamics simulation.
    Frost CV; Zacharias M
    Proteins; 2020 Dec; 88(12):1592-1606. PubMed ID: 32666627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of conformation- and sequence-specific antibodies against amyloid β.
    Perchiacca JM; Ladiwala AR; Bhattacharya M; Tessier PM
    Proc Natl Acad Sci U S A; 2012 Jan; 109(1):84-9. PubMed ID: 22171009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers.
    Silverman JM; Gibbs E; Peng X; Martens KM; Balducci C; Wang J; Yousefi M; Cowan CM; Lamour G; Louadi S; Ban Y; Robert J; Stukas S; Forloni G; Hsiung GR; Plotkin SS; Wellington CL; Cashman NR
    ACS Chem Neurosci; 2018 Jul; 9(7):1591-1606. PubMed ID: 29614860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of the β-amyloid(4-10) epitope of plaque specific Aβ antibodies by affinity-mass spectrometry using alanine site mutation.
    Ștefănescu R; Lupu L; Manea M; Iacob RE; Przybylski M
    J Pept Sci; 2018 Jan; 24(1):. PubMed ID: 29322650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β oligomer specificity mediated by the IgM isotype--implications for a specific protective mechanism exerted by endogenous auto-antibodies.
    Lindhagen-Persson M; Brännström K; Vestling M; Steinitz M; Olofsson A
    PLoS One; 2010 Nov; 5(11):e13928. PubMed ID: 21085663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aβ(M1-40) and Wild-Type Aβ40 Self-Assemble into Oligomers with Distinct Quaternary Structures.
    Bouchard JL; Davey TC; Doran TM
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31208071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer's disease.
    Murakami K
    Biosci Biotechnol Biochem; 2014; 78(8):1293-305. PubMed ID: 25130729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of β-amyloid oligomer recognition with a conformational antibody fragment.
    Morgado I; Wieligmann K; Bereza M; Rönicke R; Meinhardt K; Annamalai K; Baumann M; Wacker J; Hortschansky P; Malešević M; Parthier C; Mawrin C; Schiene-Fischer C; Reymann KG; Stubbs MT; Balbach J; Görlach M; Horn U; Fändrich M
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12503-8. PubMed ID: 22814377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A generic method for design of oligomer-specific antibodies.
    Brännström K; Lindhagen-Persson M; Gharibyan AL; Iakovleva I; Vestling M; Sellin ME; Brännström T; Morozova-Roche L; Forsgren L; Olofsson A
    PLoS One; 2014; 9(3):e90857. PubMed ID: 24618582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A coiled conformation of amyloid-β recognized by antibody C706.
    Teplyakov A; Obmolova G; Gilliland GL
    Alzheimers Res Ther; 2017 Aug; 9(1):66. PubMed ID: 28830506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of a monoclonal antibody with high affinity for soluble Abeta oligomers.
    Ying Z; Xin W; Jin-Sheng H; Fu-Xiang B; Wei-Min S; Xin-Xian D; Xiao-Bo W; Yi-Qin L; Xian-Xian Z; Hong-Gang H; Xiang-Lei P; Yan-Peng Z; Ling-Ling H; Tao H
    Hybridoma (Larchmt); 2009 Oct; 28(5):349-54. PubMed ID: 19857116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease modifying therapies for Alzheimer's disease targeting Aβ oligomers: implications for therapeutic mechanisms.
    Matsubara E; Takamura A; Okamoto Y; Oono H; Nakata T; Wakasaya Y; Kawarabayashi T; Shoji M
    Biomed Res Int; 2013; 2013():984041. PubMed ID: 24063020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping conformational ensembles of aβ oligomers in molecular dynamics simulations.
    Kim S; Takeda T; Klimov DK
    Biophys J; 2010 Sep; 99(6):1949-58. PubMed ID: 20858441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of recognition of amyloid-β (Aβ) monomer, oligomer, and fibril by homologous antibodies.
    Zhao J; Nussinov R; Ma B
    J Biol Chem; 2017 Nov; 292(44):18325-18343. PubMed ID: 28924036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer's disease.
    Wang SW; Liu DQ; Zhang LX; Ji M; Zhang YX; Dong QX; Liu SY; Xie XX; Liu RT
    Alzheimers Res Ther; 2017 Jun; 9(1):41. PubMed ID: 28592267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-β in a fraction of amyloid-β deposits in Alzheimer's disease without cross-reactivity with other protein aggregates.
    Venkataramani V; Wirths O; Budka H; Härtig W; Kovacs GG; Bayer TA
    J Alzheimers Dis; 2012; 29(2):361-71. PubMed ID: 22232007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing and trapping a sensitive conformation: amyloid-β fibrils, oligomers, and dimers.
    Fawver JN; Duong KT; Wise-Scira O; Petrofes Chapa R; Schall HE; Coskuner O; Zhu X; Colom LV; Murray IV
    J Alzheimers Dis; 2012; 32(1):197-215. PubMed ID: 22785403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.